European Medicines Agency responds to criticism over clinical trial reporting

Author (Corporate)
Series Title
Series Details 6.6.11
Publication Date 06/06/2011
Content Type

The European Medicines Agency (EMA), on 1 June 2011, responded to an online article, published by the British Medical Journal (BMJ) on 25 May 2011, which called for better reporting of the outcome of clinical trials in European public assessment reports (EPARs). The Agency's letter, which was published on the BMJs website, explains that transparency of its scientific discussions has been a priority since the Agency's establishment in 1995.
Source Link http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2011/06/news_detail_001269.jsp&murl=menus/news_and_events/news_and_events.jsp&mid=WC0b01ac058004d5c1&jsenabled=true
Related Links
Website: EU Clinical Trials Register https://www.clinicaltrialsregister.eu/
EMA: Access to documents http://www.ema.europa.eu/ema/index.jsp?curl=pages/document_library/document_listing/document_listing_000312.jsp&murl=menus/document_library/document_library.jsp&mid=WC0b01ac0580022517
EMA: Human medicines: European public assessment report (EPARs) http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d125
EMA: Veterinary medicines: European Public Assessment Reports (EPARs) http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/vet_epar_search.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058008d7a8
Subject Categories , ,
Countries / Regions